HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Alexandre S Crippa Selected Research

Anti-Anxiety Agents (Anxiolytics)

5/2022The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event.
1/2021Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.
1/2020Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.
1/2019Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.
12/2015Reprint of "Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)".
8/2015Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio).
1/2011Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
5/2010[Therapeutical use of the cannabinoids in psychiatry].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José Alexandre S Crippa Research Topics

Disease

7Schizophrenia (Dementia Praecox)
10/2021 - 03/2010
6Social Phobia
10/2019 - 06/2007
5Memory Disorders (Memory Loss)
01/2022 - 02/2014
4Psychotic Disorders (Schizoaffective Disorder)
10/2021 - 01/2011
4Parkinson Disease (Parkinson's Disease)
10/2020 - 11/2014
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 07/2012
3Cognitive Dysfunction
05/2022 - 03/2010
3Panic Disorder (Panic Attack)
06/2014 - 10/2006
2COVID-19
10/2022 - 01/2021
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
05/2022 - 05/2022
2Tremor (Tremors)
01/2021 - 01/2020
2Dyskinesias (Dyskinesia)
10/2020 - 02/2019
2Mood Disorders (Mood Disorder)
01/2019 - 06/2016
2Iron Overload
01/2018 - 02/2014
2Substance-Related Disorders (Drug Abuse)
07/2016 - 06/2016
1Wounds and Injuries (Trauma)
05/2022
1Exanthema (Rash)
01/2022
1Essential Tremor (Essential Tremors)
01/2021
1Sleepiness
01/2021
1Emotional Exhaustion
01/2021
1Diarrhea
01/2021
1Nausea
01/2021
1Vomiting
01/2021
1Chronic Pain
01/2021
1Lethargy
06/2020
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2020
1Epilepsy (Aura)
08/2018
1Mania (Manias)
02/2016
1Neuroblastoma
08/2015
1Alcoholism (Alcohol Abuse)
11/2013
1Paranoid Schizophrenia (Delusional Disorder)
08/2011
1Marijuana Abuse (Cannabis Abuse)
05/2010
1Trismus (Lockjaw)
06/2009
1Weight Loss (Weight Reduction)
06/2009
1Obesity
06/2009
1Treatment-Resistant Schizophrenia
09/2006
1Lipoma (Lipomata)
02/2002

Drug/Important Bio-Agent (IBA)

19CannabidiolIBA
10/2022 - 09/2006
8Anti-Anxiety Agents (Anxiolytics)IBA
05/2022 - 05/2010
4Pharmaceutical PreparationsIBA
05/2022 - 02/2016
4EndocannabinoidsIBA
10/2020 - 08/2011
4CannabinoidsIBA
02/2019 - 06/2009
3CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2021 - 06/2009
3IronIBA
01/2018 - 02/2014
2Therapeutic UsesIBA
10/2022 - 02/2019
2Dronabinol (THC)FDA LinkGeneric
01/2021 - 05/2010
2Transaminases (Aminotransferases)IBA
01/2021 - 06/2020
2Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2019
2Levodopa (L Dopa)FDA LinkGeneric
10/2020 - 02/2019
2Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2014
2SynaptophysinIBA
01/2018 - 02/2014
2Caspase 3 (Caspase-3)IBA
01/2018 - 02/2014
2Caffeine (No Doz)FDA LinkGeneric
12/2015 - 08/2015
2Duloxetine Hydrochloride (Cymbalta)FDA Link
06/2007 - 10/2006
1Antiviral Agents (Antivirals)IBA
10/2022
1Estrogens (Estrogen)FDA Link
01/2022
1Polytetrafluoroethylene (Teflon)FDA Link
10/2021
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2021
1Valproic Acid (Depakote)FDA LinkGeneric
06/2020
1Clobazam (HR 376)IBA
06/2020
1MetalsIBA
01/2018
1Caspase 8 (Caspase-8)IBA
01/2018
1Cytochromes c (Cytochrome c)IBA
01/2018
1Caspase 9IBA
01/2018
1AlkaloidsIBA
07/2016
1Lysergic Acid Diethylamide (LSD)IBA
06/2016
1Psilocybin (Psilocibin)IBA
06/2016
1Neuroprotective AgentsIBA
08/2015
1N-Methylaspartate (NMDA)IBA
06/2014
1Aminobutyrates (Aminobutyric Acid)IBA
06/2014
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
06/2014
1Kainic Acid Receptors (Kainate Receptor)IBA
06/2014
1Antipsychotic Agents (Antipsychotics)IBA
01/2014
1Illicit Drugs (Recreational Drugs)IBA
11/2013
1Pregabalin (Lyrica)FDA Link
10/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2012
1KetamineFDA LinkGeneric
10/2012
1Indicators and Reagents (Reagents)IBA
02/2012
1Messenger RNA (mRNA)IBA
08/2011
1anandamide (arachidonylethanolamide)IBA
08/2011
1Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2011
1agomelatine (S20098)IBA
10/2010
1Fluoxetine (Prozac)FDA LinkGeneric
06/2009
1RimonabantIBA
06/2009
1Clozapine (Clozaril)FDA LinkGeneric
02/2002

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2021 - 07/2012
1Aftercare (After-Treatment)
01/2021
1Therapeutics
01/2021